These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 5985259)

  • 21. Ribosylation by mycobacterial strains as a new mechanism of rifampin inactivation.
    Dabbs ER; Yazawa K; Mikami Y; Miyaji M; Morisaki N; Iwasaki S; Furihata K
    Antimicrob Agents Chemother; 1995 Apr; 39(4):1007-9. PubMed ID: 7785970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Studies on isolated rat hepatocytes (5). Effects on platonin].
    Hatano M; Yamada T; Yoshida A; Miyata K; Okusawa S; Shimizu S; Miura K; Ishihara M
    Josai Shika Daigaku Kiyo; 1983; 12(3):459-64. PubMed ID: 6586229
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of prototypical inducing agents on P-glycoprotein and CYP3A expression in mouse tissues.
    Matheny CJ; Ali RY; Yang X; Pollack GM
    Drug Metab Dispos; 2004 Sep; 32(9):1008-14. PubMed ID: 15319343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Studies on the metabolic effect of growth promotors, using nitrovin as a model. 2. Studies on the enterohepatic circulation of 14C-labeled nitrovin in the rat].
    Struck S; Günther KD; Hillemeir H; ter Meulen U
    Z Tierphysiol Tierernahr Futtermittelkd; 1980; 43(4-5):191-6. PubMed ID: 7405409
    [No Abstract]   [Full Text] [Related]  

  • 25. Biliary and gastrointestinal excretion of chromium after administration of Cr-III and Cr-VI in rats.
    Manzo L; Di Nucci A; Edel J; Gregotti C; Sabbioni E
    Res Commun Chem Pathol Pharmacol; 1983 Oct; 42(1):113-25. PubMed ID: 6648036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elucidating the effect of final-day dosing of rifampin in induction studies on hepatic drug disposition and metabolism.
    Lam JL; Shugarts SB; Okochi H; Benet LZ
    J Pharmacol Exp Ther; 2006 Nov; 319(2):864-70. PubMed ID: 16905688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NTP Toxicology and Carcinogenesis Studies of Methyleugenol (CAS NO. 93-15-2) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2000 Jul; 491():1-412. PubMed ID: 12563349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Se-75-labeled bile acid analogs, new radiopharmaceuticals for investigating the enterohepatic circulation.
    Boyd GS; Merrick MV; Monks R; Thomas IL
    J Nucl Med; 1981 Aug; 22(8):720-5. PubMed ID: 7264761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Physico-chemical properties of DNA-dependent RNA-polymerase from Escherichia coli and its subunits].
    Deshko TN; Kudelina IA; Surin AM
    Bioorg Khim; 1984 May; 10(5):641-7. PubMed ID: 6388581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of pharmacokinetic profiles and metabolic pathways of 20(S)-ginsenoside Rh1 in vivo and in vitro.
    Lai L; Hao H; Liu Y; Zheng C; Wang Q; Wang G; Chen X
    Planta Med; 2009 Jun; 75(8):797-802. PubMed ID: 19266426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of mutagenic glucuronide formation from benzo(a)pyrene in the nonrecirculating perfused rat liver.
    Kari FW; Kauffman FC; Thurman RG
    Cancer Res; 1984 Nov; 44(11):5073-8. PubMed ID: 6488167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholesteryl esters from oxidized low-density lipoproteins are in vivo rapidly hydrolyzed in rat Kupffer cells and transported to liver parenchymal cells and bile.
    Pieters MN; Esbach S; Schouten D; Brouwer A; Knook DL; Van Berkel TJ
    Hepatology; 1994 Jun; 19(6):1459-67. PubMed ID: 8188177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolism of tacrolimus (FK 506) in rat liver microsomes. Effect of rifampin and dexamethasone.
    Prasad ; Tata NV; Subbotina N; Burckart G; Swaminathan A; Gusev AI; Hercules DM; Venkataramanan R
    Res Commun Mol Pathol Pharmacol; 1997 Apr; 96(1):107-10. PubMed ID: 9178371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of rifampin in infants and children: relevance to prophylaxis against Haemophilus influenzae type b disease.
    McCracken GH; Ginsburg CM; Zweighaft TC; Clahsen J
    Pediatrics; 1980 Jul; 66(1):17-21. PubMed ID: 6967586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic study of the interaction between rifampin and delavirdine mesylate.
    Borin MT; Chambers JH; Carel BJ; Gagnon S; Freimuth WW
    Clin Pharmacol Ther; 1997 May; 61(5):544-53. PubMed ID: 9164416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Ethanol, in low doses, increases the biliary excretion of bilirubin in isolated and perfused rat liver].
    Bellobuono A; Bellati G; Tempini S; Vitali L; Ideo G
    Boll Soc Ital Biol Sper; 1980 Feb; 56(3):208-11. PubMed ID: 7370112
    [No Abstract]   [Full Text] [Related]  

  • 38. [Retention of rifampicin in rat's organs].
    Zwolska-Kwiek Z; Araszkiewicz Z; Kwiek S
    Pneumonol Pol; 1980 Apr; 48(4):249-55. PubMed ID: 7375376
    [No Abstract]   [Full Text] [Related]  

  • 39. Rifampicin.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1980; 24():243-58. PubMed ID: 7009395
    [No Abstract]   [Full Text] [Related]  

  • 40. Rifampicin inhibition of ribonucleic acid and protein synthesis in normal and ethylenediaminetetraacetic acid-treated Escherichia coli.
    Reid P; Speyer J
    J Bacteriol; 1970 Oct; 104(1):376-89. PubMed ID: 4990763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.